Unlock the Potential of Cargenx at the Upcoming BofA Securities 2023 Health Care Conference

argenx (Euronext & Nasdaq: ARGX), a pioneering global immunology company devoted to improving the lives of those suffering from severe autoimmune diseases, will be hosting a fireside chat at the BofA Securities 2023 Health Care Conference on Tuesday, May 9th, 2023 at 8:00 a.m. P.T. in Las Vegas, NV.

This event marks a momentous opportunity for members of management from argenx to share their insights and progress in delivering on their mission to change the lives of those living with autoimmune diseases.

About argenx

At argenx, we are passionate about helping those who suffer from severe autoimmune diseases. Through our Immunology Innovation Program (IIP), we are dedicated to partnering with leading academic researchers to bring immunology breakthroughs to life in the form of novel antibody-based medicines.

We are proud to have developed and commercialized the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S., the EU and UK, and Japan. Currently, we are exploring the potential of efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within our therapeutic franchises. We are excited to be playing a part in changing the lives of those with autoimmune diseases.

Leave a Comment